GlassScriptPhysician profile
Jennifer A Jordan
NPI 1003808528
$3,339.53
in general payments reported to CMS, 2019-2025
14 companies · $1,118 in 2025
The $1,118 reported for 2025 was more than what 81% of Otolaryngology providers received nationally (typical 2025 total: $317).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $295 · 2020: $62.42 · 2021: $25.85 · 2022: $1,025 · 2023: $483 · 2024: $332 · 2025: $1,118.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,932.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,932.08 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Davol INC. | $1,757.90 | 2022-2025 | Phasix Mesh |
| Inspire Medical Systems, INC. | $373.33 | 2023-2025 | Inspire |
| Allergan, INC. | $291.68 | 2022 | |
| Integra Lifesciences Corporation | $212.23 | 2025 | Inspira Air, Acclarent Aera, Relieva Spinplus Nav |
| Stryker Corporation | $161.65 | 2019-2020 | |
| Neurent Medical Limited | $145.83 | 2025 | Neuromark Radiofrequency Console, Neuromark System |
| Regeneron Healthcare Solutions, INC. | $137.68 | 2019-2025 | Dupixent |
| Acclarent, INC | $78.67 | 2019-2022 | |
| Genzyme Corporation | $60.65 | 2024-2025 | |
| Olympus America INC. | $48.30 | 2019 | |
| Intersect Ent, INC. | $26.64 | 2019 | |
| Arrinex, INC. | $16.54 | 2019 | |
| Optinose US, INC. | $14.63 | 2019 | |
| Glaxosmithkline, LLC. | $13.80 | 2025 | Nucala |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jennifer Jordan listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.